Can Oncotype DX testing be omitted in invasive breast...

  • Main
  • 2020 / 10
  • Can Oncotype DX testing be omitted in invasive breast...
The Breast Journal 2020 / 10

Can Oncotype DX testing be omitted in invasive breast cancer patients with clinicopathologic factors predicting very high pretest probability of a concordant result?

Kapadia, Sonam, Gudiwada, Sai Priyanka, Kaji, Amy H., Chlebowski, Rowan T., Venegas, Rose, Ozao‐Choy, Junko, Dauphine, Christine
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Breast Journal
DOI:
10.1111/tbj.14068
Date:
October, 2020
File:
PDF, 324 KB
2020
Conversion to is in progress
Conversion to is failed